Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase

NCT00185523 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00185523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase
Lead sponsor
Stanford University
Phase
Observational
Overall status
Terminated
Start date
May 31, 2002
Completion date
April 30, 2009
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, leukemia acute lymphoid leukemia (all), leukemia acute myeloid leukemia (aml), leukemia acute promyelocytic leukemia (apl), leukemia chronic lymphocytic leukemia (cll), leukemia chronic myelogenous leukemia (cml), leukemia, lymphocytic, acute